Development of an Opioid Withdrawal Clinical Outcome Assessment
Key facts
- Who runs it
- University of Maryland, Baltimore
- Where
- Baltimore, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 30 people, planned
- Starts
- 1 Dec 2026
- Expected to end
- 30 Sept 2028
- Type of study
- Observational, 2 groups
- Record updated
- 10 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Past year opioid use disorder, determined by (a) enrollment in current treatment for opioid use disorder and/or (b) an opioid-positive saliva test
- Fluent in English
- Has experience with opioid withdrawal at least once in the past 30 days
Who cannot take part
- Previously participated in affiliated Focus Group study
- Unable to provide informed consent due to cognitive impairment
- History of psychosis or mania as determined by the MINI
- Being pregnant or breastfeeding
- Exhibiting suicidal behavior in the past 30 days as determined by the C-SSRS
- Circumstances that could interfere with study participation
Where in United States
- Kahlert Institute for Addiction MedicineBaltimore, United StatesContact: Kelly E Dunn, Ph.D., MBANot yet recruiting
About the trial
What the trial wants to find out
Withdrawal management strategies are currently the most utilized and ubiquitous intervention for opioid use disorder in the US, yet existing measures of opioid withdrawal lack Food and Drug Administration (FDA) qualification. This project will develop and validate a clinical outcome assessment (COA) for opioid withdrawal,essential for standardizing withdrawal mitigation strategies and establishing best practices. In line with the FDA's drug development tool qualification guidelines, our methodological process will involve conducting focus groups with persons with lived experience of opioid withdrawal for concept elicitation, refining these concepts through cognitive interviews, and conducting construct and longitudinal validations of the new assessment in laboratory settings and across diverse treatment contexts.
The 2 groups in the trial
- WIthdrawal assessment_precipitated session
Assessment of withdrawal following elicitation
- Withdrawal assessment_spontaneous
Assessment of withdrawal during a period of opioid abstinence
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Development of an Opioid Withdrawal Clinical Outcome Assessment Among Persons With Opioid Use Disorder
- Record updated
- 10 November 2026